Details of the Drug Formulaction

General Information of Drug Formulation (ID: F15095)

• Formulation Name: Naratriptan 1 mg tablet
• Company: Teva Pharmaceuticals

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Naratriptan	(DMO50U2)	Headache	8A80-8A84	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Carmellose sodium	(E00625)	Not Available	Disintegrant
FD&C blue no. 1	(E00263)	19700	Colorant
Ferric hydroxide oxide yellow	(E00539)	23320441	Colorant
Ferrosoferric oxide	(E00231)	14789	Colorant
Lactose monohydrate	(E00393)	104938	Binding agent; Diluent; Dry powder inhaler carrier; Lyophilization aid
Magnesium stearate	(E00208)	11177	lubricant
Polyethylene glycol 4000	(E00654)	Not Available	Coating agent; Diluent; Ointment base; Plasticizing agent; Solvent; Suppository base; lubricant
Polyvinyl alcohol	(E00666)	Not Available	Coating agent; Emulsion stabilizing agent; Film/Membrane-forming agent
Talc	(E00520)	16211421	Anticaking agent; Diluent; Glidant; lubricant
Titanium dioxide	(E00322)	26042	Coating agent; Colorant; Opacifying agent